Afro-Caribbean patients with severe kidney disease at greater risk of hospitalisation from COVID-19

November 19, 2020

Afro-Caribbean people with end stage kidney disease (ESKD) are more likely to be hospitalised with COVID-19 than other ethnicities, a study has found.

Research published today in Nephrology by King's College London and Guy's and St Thomas' NHS Foundation Trust investigated the link between ethnicity and ESKD. They found patients of Afro-Caribbean ethnicity have a four-fold increased risk of being hospitalised with COVID-19 when compared to kidney transplant patients attending for routine care.

The study examined 39 people with diabetes related ESKD hospitalised with COVID-19 at Guy's and St Thomas' between March and April 2020. Of the hospitalised cohort, 73% of patients with a kidney transplant and 54% of haemodialysis patients were of Afro-Caribbean ethnicity. By comparison in patients attending hospital for routine care 18% of kidney transplant patients and 42% of haemodialysis patients are of Afro-Caribbean ethnicity.

The study concluded that ESKD is associated with a high mortality rate of 36% among severely ill patients hospitalised with COVID-19.

First author of the study, Dr Antonella Corcillo from the School of Cardiovascular Medicine and Sciences at King's College London said: "There is very little information on the clinical features and outcomes in patients with ESKD admitted with COVID-19 in the UK. Patients with ESKD are at high risk of severe COVID-19 and often have a poor prognosis. The mortality rate of patients hospitalised, as they had very severe COVID-19, was high at 36% and similar to other recent studies internationally. We observed a disproportionately high prevalence of people of Afro-Caribbean ethnicity being hospitalised. We also saw that low blood glucose levels (hypoglycaemia) were common during hospitalisation in this high-risk population and that adjustment of diabetes treatment was frequently required."

Senior author, Dr Janaka Karalliedde from King's College London, said: "People with ESKD are a high-risk group and are vulnerable to severe COVID-19 infection. When we compared the prevalence of Afro-Caribbean ethnicity in kidney transplant patients admitted with severe COVID-19 to the population of transplant patients attending for routine care at our hospital we observed a more than a four-fold increase in patients of Afro-Caribbean origin being admitted with COVID-19. Further studies and research are urgently required to understand and explain this observation of disproportionate risk in patients of Afro-Caribbean origin. Our data also confirm that the management of diabetes in the setting of severe COVID-19 infection is very challenging and reinforce the importance of integrated multidisciplinary care and teamwork for patients with diabetes hospitalized with COVID-19."

Limitations of this study include its relatively small sample size and that, as it is a cross-sectional study, it is unable to identify causal relationships between ethnicity and severe COVID-19 outcomes.
-end-


King's College London

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.